Development of VR-Enabled PyMOL Modules for Immersive Antibody Design

We present an extension to the open-source molecular visualization software PyMOL designed to facilitate antibody study and design in both virtual reality (VR) and traditional desktop environments. Our contribution augments PyMOL with paratope estimation, integration of molecular dynamics simulations, machine learning–guided antibody evolution and enhanced VR interactivity.

Publication Details

Journal
Electronic Theses and Dissertations Repository (University of Pisa)
Published
2025-05-25
Primary Topic
Monoclonal and Polyclonal Antibodies Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of VR-Enabled PyMOL Modules for Immersive Antibody Design

Electronic Theses and Dissertations Repository (University of Pisa)
Monoclonal and Polyclonal Antibodies Research
article

Development of VR-Enabled PyMOL Modules for Immersive Antibody Design

article en

Abstract

We present an extension to the open-source molecular visualization software PyMOL designed to facilitate antibody study and design in both virtual reality (VR) and traditional desktop environments. Our contribution augments PyMOL with paratope estimation, integration of molecular dynamics simulations, machine learning–guided antibody evolution and enhanced VR interactivity.

Electronic Theses and Dissertations Repository (University of Pisa)
Openalex Percentile: Top 37%
Monoclonal and Polyclonal Antibodies Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.